Skip to main content
TipRanks
Go Ultimate75% OFF

Ron Best Insider Profile

4 Followers

Ron Best, Director at Mayne Pharma Group, holds 1.59M shares in Mayne Pharma Group (Ticker: MAYNF). Most recently, Ron Best Bought 18,711 shares of Mayne Pharma Group on Dec 21, 2016 for an estimated value of $23.74K.

Ron Best's Trading History

MAYNF
Mayne Pharma Group
Dec 21, 2016DirectorInformative Buy23.74K$3.48M
MAYNF
Insider Shares: 1.59M (10.62%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 21, 2016Informative BuyAU$23.74K18,711AU$1.27-45.80%―
Aug 16, 2016Informative BuyAU$98.41K76,879AU$1.28-62.80%―
Jul 07, 2016Informative BuyAU$1.82M1,402,289AU$1.30-44.30%―
Jul 07, 2016Uninformative SellAU$2.42M2,450,000AU$0.99――
Sep 07, 2015Informative BuyAU$73.30K68,000AU$1.08+131.70%―

You May Also Like

Ron Best insider profile FAQ

What is the percentage of profitable transactions made by Ron Best?
The percentage of profitable transactions made by Ron Best is 33%.
What is the average return per transaction made by Ron Best?
The average return per transaction made by Ron Best is -2.40%.
What stocks does Ron Best hold?
Ron Best holds: MAYNF stocks.
What was Ron Best’s latest transaction?
Ron Best’s latest transaction was an Informative Buy of $23.74K.
What was Ron Best's most profitable transaction?
Ron Best’s most profitable transaction was an Informative Buy of MAYNF stock on September 7, 2015. The return on the trade was 131.70%.
What is Ron Best's role in Mayne Pharma Group?
Ron Best's role in Mayne Pharma Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.